As part of a wider plan to stem rising pharmaceutical spending in Spain

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.392, 2002-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plan to curb Spanish pharma spending to save millions

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 276, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Pharmaceutical spending in Italy slowed by price cut

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 391, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Measuring US Pharmaceutical Industry R&D Spending

By Golec Joseph Vernon John

PharmacoEconomics, Vol. 26, Iss. 12, 2008-01 ,pp. : 1005-1017

Adis International

Access to resources Recommend Favorite

WHY MEDICARE PRICE NEGOTIATION IS THE WRONG PRESCRIPTION FOR RISING DRUG SPENDING

Journal Of Policy Analysis And Management, Vol. 35, Iss. 4, 2016-09 ,pp. : 956-963

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stem Cells in Pharmaceutical Biotechnology

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 11, 2011-11 ,pp. : 1760-1773

Bentham Science Publishers

Access to resources Recommend Favorite